Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 3,6,6-trimethyl-6,7-dihydro-1H-indol-4(5H)-one | HCID 24820798 | — |
| Reactant | 1009036-31-0 | HCID 25059434 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 25060729 | HCID 25060729 | — |
Reaction Steps
Sodium hydride (60% suspension in mineral oil, 50 mg, 1.3 mmol) is added to a solution of 3,6,6-Trimethyl-1,5,6,7-tetrahydro-indol-4-one (50 mg, 0.29 mmol) in anhydrous DMF (1 mL). This mixture is stirred at room temperature for 5 minutes before 7,8-Difluoro-quinazolin-4-ylamine (75 mg, 0.41 mmol) is added. After 10 minutes at room temperature, the reaction mixture is heated at 50° C. overnight. The cooled reaction mixture is partitioned between ethyl acetate and water to remove DMF, and the organic layer is concentrated to dryness via Rotovap. The resulting crude residue is further purified through two consecutive silica gel columns (0%-8% of methanol in DCM, gradient) to afford 1-(4-Amino-8-fluoro-quinazolin-7-yl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-indol-4-one (15 mg, not optimized) as white solid. LC/MS m/z=339 [M+H]+.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07678803B2 |
|---|
| Source dataset | uspto-grants-2010_03 |
|---|
| ORD ID | ord-e1d71b929efb43378e9777baf1feb46b |
|---|
| Source note | uspto-grants-2010_03 |
|---|